Results 161 to 170 of about 10,268 (212)

Comparison of Vonoprazan Triple Therapy, Bismuth Quadruple Therapy, and Amoxicillin Therapy for Helicobacter pylori Infection: A Systematic Review. [PDF]

Cureus
Iqbal ZU, Bukhari SMH, Rana SS, Dilshad RA, Saeed A, Sta Ines MCA, Haroon A.   +6 more
europepmc   +1 more source

Proton pump inhibitors use and risk of type 2 diabetes mellitus: correlation analysis, prediction model construction, and key genes identification. [PDF]

Front Pharmacol
Liang C, Zhang Y.
europepmc   +1 more source

Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status. [PDF]

Pharmacoepidemiol Drug Saf
Lo Re V, Newcomb CW, Carbonari DM, Mezochow AK, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Torgersen J.   +16 more
europepmc   +1 more source

Vonoprazan-based therapy versus standard regimen for Helicobacter pylori infection management in Egypt: an open-label randomized controlled trial. [PDF]

Sci Rep
Shekeban YM, Hamdy NA, Header DA, Ahmed SM, Helmy MM.   +4 more
europepmc   +1 more source

Response to the letter to the editor: Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris. [PDF]

Emerg Microbes Infect
Salama EA, Elgammal Y, Wijeratne A, Lanman NA, Utturkar SM, Farhangian A, Li J, Meunier B, Hazbun TR, Seleem MN.   +9 more
europepmc   +1 more source

Severe Hypomagnesemia in a Patient Treated Using Carboplatin Co-Administered with Vonoprazan. [PDF]

Case Rep Oncol
Taniguchi O, Saito Y, Yamaguchi Y, Sakai M, Ikezawa Y, Sakakibara-Konishi J, Eguchi M, Takekuma Y, Sugawara M.   +8 more
europepmc   +1 more source

So Many Choices, So Little Value: Potential Savings from Selecting Cost-Effective Proton Pump Inhibitors. [PDF]

Pharmacoecon Open
Kwon HY.
europepmc   +1 more source

The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial. [PDF]

BMJ Open
Jones M, Cahn A, Chaudhuri N, Clark AB, Forrest I, Hammond M, Jones S, Maher TM, Parfrey H, Raghu G, Simpson AJ, Smith JA, Spencer LG, Thickett D, Vale L, Wahed S, Ward C, Wilson AM.   +17 more
europepmc   +1 more source

Enantioselective Binding of Proton Pump Inhibitors to Alpha1-Acid Glycoprotein and Human Serum Albumin-A Chromatographic, Spectroscopic, and In Silico Study. [PDF]

Int J Mol Sci
Dombi G, Tyukodi L, Dobó M, Molnár G, Rozmer Z, Szabó ZI, Fiser B, Tóth G.   +7 more
europepmc   +1 more source